Work

Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors

Year: 2007

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-007-9077-0

Authors: Catherine Delbaldo, Eric Raymond, Karina Vera, Luz Hammershaimb, Karen Kaucic, Stéphanie Lozahic, Michel Marty, Sandrine Faivre

Institutions: Hôpital Beaujon, Hôpital Saint-Louis

Language: English

Topic: Cell Adhesion Molecules Research

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1970267589

FWCI: 5.132

Cites: 39

Cited by: 101

Related to: 10